Articles tagged with Obesity
A CU Anschutz study reveals reduced mitochondrial efficiency in healthy yet sedentary individuals, which may precede the development of major diseases like cancer, diabetes, and Alzheimer's. Regular exercise acts as a literal shield for cellular health, helping mitochondria seamlessly switch between burning fat and carbohydrates.
Researchers found that bariatric surgery can lead to a significantly higher risk of developing alcohol problems. The altered anatomy affects how the body processes and absorbs alcohol, leading to faster intoxication and prolonged recovery times.
The GSA has released a new online version of the KAER Toolkit, providing practical tools to integrate evidence-based obesity care into routine practice. The toolkit emphasizes treating obesity as a chronic disease and includes strategies for managing older adults using medications.
Rates of new obesity cases rose by 4% between 2019 and 2025, with the largest increases seen among young adults. The study also found significant disparities in obesity rates across sociodemographic groups and geographical regions, highlighting the need for deep-seated change to address the underlying factors driving obesity.
A new study published in Cell Metabolism found that a low-protein, amino acid-supplemented 'longevity diet' improved cardiometabolic markers and reduced frailty and fat mass in mice. The diet was associated with longer healthy lifespan and better metabolic health in both mice and humans.
A new study analyzing 86,000 Norwegian children found that the association between parental body mass index (BMI) and childhood BMI is largely explained by shared genetics. Genetic effects accounted for an estimated 79% of the statistical association between a mother's BMI and her child's BMI at age 8.
A recent study found that maternal obesity and excessive pregnancy weight gain significantly increased the risk of childhood obesity by age 3. Researchers tracked nearly 3,000 mother-child pairs and discovered that excess pregnancy weight gain was common, affecting about four in 10 mothers.
A systematic review and network meta-analysis found that combining lifestyle treatment with obesity medications resulted in significant short-term weight loss and improved body composition in adolescents. Health behavior remained crucial to effective weight management.
A study found that nearly 4 in 10 patients stopped GLP-1 medication within the first year and nearly two-thirds restarted therapy within two years. The researchers also identified sociodemographic, clinical, and provider-level predictors of discontinuation, including Medicaid or Medicare status, Black patients, and side effects.
A study presented at ENDO 2026 found semaglutide was associated with a 15% reduction in bone fractures and greater weight loss compared to other anti-obesity medications. The results suggest that semaglutide may have beneficial effects on bone health in people with type 2 diabetes.
A study found that adults taking GLP-1 receptor agonist medications experienced significant decreases in daily step counts and moderate-to-vigorous physical activity, highlighting the need for targeted interventions to promote exercise alongside obesity treatment.
A recent study of 42,000 adults taking blood pressure medications and GLP-1s found higher rates of hypotension events, including dizziness and fainting. The study highlights a potential safety concern for patients aged 65 and older and those with diabetes.
A study published in The Lancet found that Chile's comprehensive food policies, including labelling and advertising bans, have a real-world impact on reducing child obesity. After implementing the Food Labelling and Advertising Law in 2016, children who had been at school for 18 months showed a lower risk of overweight or obesity compa...
The American Society for Nutrition (ASN) and The Obesity Society (TOS) have formed a strategic alliance to accelerate progress in both fields. This collaboration will drive evidence-based solutions that shape practice, inform policy, and improve health outcomes worldwide.
A new study by Pennington Biomedical and collaborators found that Americans with the highest levels of obesity are undergoing fewer surgical procedures overall. Despite the increasing prevalence of extreme obesity, these individuals appear to be receiving proportionally fewer surgical interventions each year. The research highlights gr...
A cohort study found that smartphone acquisition at age 13 was linked to increased risk of insufficient sleep at age 14. Excessive smartphone use was also tied to higher odds of depression and obesity. Limiting screen time may protect adolescents from these outcomes.
A study analyzing insurance claims data found similar risks between continued and non-continued GLP-1RA medication use during early pregnancy. The authors conclude that further research is needed to better understand the safety of GLP-1RAs in pregnancy due to imprecise estimates for rare outcomes.
Mazdutide, a GLP-1 receptor dual agonist, provides clinically meaningful weight reduction in Chinese adults with obesity. However, gastrointestinal adverse reactions are more common among those taking the drug compared to placebo.
A study of over 229,000 obese adults without diabetes found that weight loss drugs, such as semaglutide and tirzepatide, were associated with a 41% decrease in the overall risk of developing obesity-related cancers. GLP-1 RAs also showed larger reductions in certain subgroups, including men and gynaecologic cancers.
Adults with both obesity and an autoimmune disease who took a GLP-1-based medication had fewer emergency department visits and lower mortality rates compared to those not taking the medication. The study analyzed data from over 26,000 adults treated in the OneFlorida+ network between 2014 and 2024.
A new study reveals how Philip Morris Companies Inc. used cigarette research and flavor engineering to design Lunchables, a successful ultra-processed food for children. The company's strategy was based on optimizing 'technical synergies' between tobacco and food divisions.
Researchers from Pennington Biomedical will showcase their latest findings on prevention, care, and cures for diabetes and obesity at the American Diabetes Association's 2026 Scientific Sessions. The sessions will highlight cutting-edge advancements driving progress in diabetes research and management.
The University of Texas at San Antonio has received significant funding from the Cancer Prevention and Research Institute of Texas to develop innovative cancer research technologies and treatments. The institution will focus on pressing cancers such as Ewing sarcoma, obesity-related endometrial cancer risk, and AI in clinical oncology.
Researchers at Pennington Biomedical published the first study to estimate pediatric obesity prevalence among US children and adolescents aged 5-18 years using the new Lancet Commission definitions. The study found that many children are already experiencing measurable health impairments associated with obesity.
The use of weight loss medications like semaglutide and tirzepatide could deepen existing health inequalities if patients lack access to nutrition advice, healthy food, and ongoing healthcare support. Researchers warn that poorer patients may face barriers to using these treatments safely and maintaining health improvements over time.
Researchers highlight latest developments in pathology, diagnosis, and treatment of MASLD and IPFD, revealing correlations with chronic diseases like liver cancer and pancreatic cancer. Innovative treatments, such as AI-driven approaches and organ-targeted therapies, show promise for precision prevention and therapy.
Weight loss after bariatric surgery is associated with better ability to cope with daily household tasks such as cleaning and grocery shopping. The study also found that maintaining weight loss for long periods results in improved functionality and independence. Patients who regained lost weight experienced poorer outcomes over time.
A study found that BMI significantly understates obesity levels in the US, with up to 50% of overweight individuals reclassified as obese under a new clinical definition. This highlights the need for healthcare providers to adopt this new measure to better identify and treat obesity-related health risks.
A new study found that nearly a quarter of adults with a normal weight BMI may still be at risk for obesity-related health complications. The research highlights the importance of considering multiple factors beyond body mass index (BMI) to accurately identify individuals at risk for these conditions.
Two new international studies found that healthy lifestyles can have a protective effect on childhood cancer survivors, reducing the risk of chronic health problems. The studies suggest that physical activity, a healthy weight, and other lifestyle factors can significantly reduce the burden of disease in adulthood.
Researchers found that obesity alters the biological changes in breast cancer cells, enabling them to survive and thrive. The study's findings could improve prediction and treatment of invasive breast cancer, reducing overtreatment and unnecessary treatments.
A new study found that drinking tomato-soy juice lowered pro-inflammatory proteins in healthy adults with obesity after four weeks. The findings hint at the juice's promise as a functional food that may help curb chronic inflammation and improve health outcomes for patients with pancreatitis.
Two studies suggest that weight loss after bariatric surgery reduces cancer risk in women, with insulin levels and genetic background playing key roles. Women carrying a specific FTO genetic variant showed significant breast cancer risk reduction.
A new study published in Nature Medicine finds that semaglutide improves weight loss and metabolic health outcomes in patients who do not respond well to bariatric surgery. Patients taking semaglutide showed significant weight loss from body fat, improved blood sugar levels, and better quality of life.
A new study reveals that metabolic dysfunction in offspring is caused by excess microRNA in sperm from obese fathers. After weight loss, these molecular marks disappear, and offspring develop normally. Research suggests that interventions promoting health and longevity may trigger an increase in this enzyme expression.
A low-calorie diet and behavioral support program significantly reduced weight in older patients with overweight and persistent atrial fibrillation at 8 months. The study found no safety concerns or impact on atrial fibrillation symptoms, cardiac remodeling, or need for further rhythm control interventions.
Researchers developed an AI framework, MouseMapper, to map disease-related changes in the entire mouse body. They found widespread inflammation and previously unrecognized damage to facial sensory nerves caused by obesity, which was also observed in human tissue.
Researchers identified a subgroup of patients who experience nearly twice the improvement in sleep apnea when treated with tirzepatide GLP-1. These strong responders have distinct characteristics, including severe upper-airway collapsibility and breathing control instability. The study aims to provide personalized treatment options for...
A new study published in eBioMedicine found that integrating measurements such as body fat percentage and waist circumference can help identify individuals at high risk of developing obesity-related diseases. The research team analysed data from 489,311 participants and found that those with an adverse adiposity profile despite normal ...
A research study, COACH trial, is testing different ways to help children and families improve their health through lifestyle changes delivered by primary care clinics. The study aims to assess the effectiveness of personalized nutrition counseling, community resources, and online interactive lessons on weight management.